Literature DB >> 19324536

Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder.

Paul Daniel Arnold1, Frank P Macmaster, Margaret A Richter, Gregory L Hanna, Tricia Sicard, Eliza Burroughs, Yousha Mirza, Phillip C Easter, Michelle Rose, James L Kennedy, David R Rosenberg.   

Abstract

In this preliminary study, 16 psychotropic-naïve pediatric patients with obsessive-compulsive disorder (OCD) were studied using magnetic resonance spectroscopy (MRS) and genotyped for six candidate polymorphisms in two glutamate system genes. A significant association was identified between the rs1019385 polymorphism of the glutamate receptor, ionotropic, N-methyl-d-aspartate 2B (GRIN2B) and decreased anterior cingulate cortex (ACC) glutamatergic concentration (Glx) but not with occipital Glx. These results suggest that GRIN2B may be associated with Glx in the ACC, a region consistently implicated in OCD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19324536      PMCID: PMC2670773          DOI: 10.1016/j.pscychresns.2009.02.005

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  28 in total

1.  Automatic quantitation of localized in vivo 1H spectra with LCModel.

Authors:  S W Provencher
Journal:  NMR Biomed       Date:  2001-06       Impact factor: 4.044

2.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

Review 3.  Spatial localization in NMR spectroscopy in vivo.

Authors:  P A Bottomley
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

Review 4.  Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop.

Authors:  A Parent; L N Hazrati
Journal:  Brain Res Brain Res Rev       Date:  1995-01

5.  Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine.

Authors:  D R Rosenberg; F P MacMaster; M S Keshavan; K D Fitzgerald; C M Stewart; G J Moore
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-09       Impact factor: 8.829

6.  Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study.

Authors:  Paul D Arnold; David R Rosenberg; Emanuela Mundo; Subi Tharmalingam; James L Kennedy; Margaret A Richter
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

Review 7.  Brain imaging in pediatric obsessive-compulsive disorder.

Authors:  Frank P MacMaster; Joseph O'Neill; David R Rosenberg
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-11       Impact factor: 8.829

8.  The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity.

Authors:  J F Leckman; M A Riddle; M T Hardin; S I Ort; K L Swartz; J Stevenson; D J Cohen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1989-07       Impact factor: 8.829

9.  The use of a priori knowledge to quantify short echo in vivo 1H MR spectra.

Authors:  J A Stanley; D J Drost; P C Williamson; R T Thompson
Journal:  Magn Reson Med       Date:  1995-07       Impact factor: 4.668

10.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra.

Authors:  S W Provencher
Journal:  Magn Reson Med       Date:  1993-12       Impact factor: 4.668

View more
  34 in total

Review 1.  Imaging-genetics applications in child psychiatry.

Authors:  Daniel S Pine; Monique Ernst; Ellen Leibenluft
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-04-09       Impact factor: 8.829

2.  Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial.

Authors:  Joseph O'Neill; John Piacentini; Susanna Chang; Ronald Ly; Tsz M Lai; Casey C Armstrong; Lindsey Bergman; Michelle Rozenman; Tara Peris; Allison Vreeland; Ross Mudgway; Jennifer G Levitt; Noriko Salamon; Stefan Posse; Gerhard S Hellemann; Jeffry R Alger; James T McCracken; Erika L Nurmi
Journal:  Neuropsychopharmacology       Date:  2017-04-04       Impact factor: 7.853

3.  An Examination of Rostral Anterior Cingulate Cortex Function and Neurochemistry in Obsessive-Compulsive Disorder.

Authors:  Brian P Brennan; Olga Tkachenko; Zachary J Schwab; Richard J Juelich; Erin M Ryan; Alison J Athey; Harrison G Pope; Michael A Jenike; Justin T Baker; William D S Killgore; James I Hudson; J Eric Jensen; Scott L Rauch
Journal:  Neuropsychopharmacology       Date:  2015-02-09       Impact factor: 7.853

4.  A locus for an auditory processing deficit and language impairment in an extended pedigree maps to 12p13.31-q14.3.

Authors:  L Addis; A D Friederici; S A Kotz; B Sabisch; J Barry; N Richter; A A Ludwig; R Rübsamen; F W Albert; S Pääbo; D F Newbury; A P Monaco
Journal:  Genes Brain Behav       Date:  2010-03-25       Impact factor: 3.449

5.  Glutamate and the Treatment of Obsessive-Compulsive Disorder.

Authors:  Frank P Macmaster; David R Rosenberg
Journal:  Psychopharm Rev       Date:  2010-05-01

6.  MRSI correlates of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.

Authors:  Joseph O'Neill; John C Piacentini; Susanna Chang; Jennifer G Levitt; Michelle Rozenman; Lindsey Bergman; Noriko Salamon; Jeffry R Alger; James T McCracken
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-10-01       Impact factor: 5.067

7.  TMPRSS9 and GRIN2B are associated with neuroticism: a genome-wide association study in a European sample.

Authors:  Nagesh Aragam; Ke-Sheng Wang; James L Anderson; Xuefeng Liu
Journal:  J Mol Neurosci       Date:  2012-12-11       Impact factor: 3.444

Review 8.  Conjoint activity of anterior insular and anterior cingulate cortex: awareness and response.

Authors:  Nick Medford; Hugo D Critchley
Journal:  Brain Struct Funct       Date:  2010-05-29       Impact factor: 3.270

Review 9.  Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity.

Authors:  Dennis L Murphy; Pablo R Moya; Meredith A Fox; Liza M Rubenstein; Jens R Wendland; Kiara R Timpano
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

10.  Glutamate system genes and brain volume alterations in pediatric obsessive-compulsive disorder: a preliminary study.

Authors:  Ke Wu; Gregory L Hanna; Philip Easter; James L Kennedy; David R Rosenberg; Paul D Arnold
Journal:  Psychiatry Res       Date:  2012-11-13       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.